All Articles

Raleigh's iconic 1969 circular tower avoids the wrecking ball, transforming into a luxury boutique hotel that proves preservation is highly profitable.

As consumers tire of juggling AI subscriptions, aggregators like Use.ai are surging. But can the multi-model workspace survive the brutal math of API economics?

Swap Commerce's acquisition of Vizby bridges the gap between AI discovery and last-mile delivery, signaling a massive shift in retail tech infrastructure.

As AI reshapes software, Synera appoints Ben Hesseldieck to bring agentic automation to the complex, high-stakes world of aerospace and automotive R&D.

As state and local agencies face pressure to modernize, a new single-award cooperative contract bypasses lengthy RFP cycles to accelerate tech adoption.

SimplePractice's new billing tools aim to keep therapists in-network, but can software overcome the systemic issues of low insurance reimbursement rates?

As cyber threats and artificial intelligence redefine global risk, a 21-lawyer exodus from a legacy firm highlights a strategic shift in the legal industry.

Amid a crippling national healthcare staffing crisis, Naples Comprehensive Health leverages a "security-first" approach to talent retention, earning back-to-back Forbes recognition.

By appointing a single president for the US and Canada, the German optics giant is positioning itself to capitalize on North America's industrial reshoring.

Michael Hursta takes the helm at the x402 Foundation, aiming to revive HTTP 402 and build a neutral, open payment rail for the booming AI agent economy.

SINTX Technologies smashed Q3 guidance with a pivot to aerospace ceramics, triggering a warrant call that forces investors to weigh dilution against growth.

Harvest Small Business Finance just secured an unprecedented AA(sf) rating for its latest securitization, signaling a major shift in alternative credit markets.

As AI-generated code floods repositories, Revyz launches Command Center for Bitbucket to close the shared responsibility gap and protect enterprise IP.

PolyPid has regained European rights to its promising infection-fighting drug. Now begins a high-stakes race to secure a partner before approval.

As R&D tax regulations grow increasingly complex, RK Partners appoints Andrew Sams as CEO to scale its boutique advisory and secure vital funding for innovators.

A monolithic 3D-printed interconnect recently tested at 20 millikelvin might be the missing piece to scale quantum computers beyond the wiring bottleneck.

C1 Fund takes its mission of accessible venture capital to major investor conferences, riding the momentum of high-profile portfolio milestones and buybacks.

As AI demand surges, AIB faces the ultimate test: funding and delivering a massive 50 MW data center without diluting existing shareholders.

ViroMissile's intravenously delivered oncolytic virus, IDOV-2, shows early signs of stable disease in Phase I, hinting at a breakthrough for metastatic cancers.

A new peer-reviewed study validates RenovoRx's targeted catheter platform, offering a strategic bridge as the company approaches its 2027 Phase III readout.